NMPA Approval

Mixed Protamine Human Insulin Injection(40R)

Approval Number

国药准字S20140002

Company通化东宝药业股份有限公司

Registration Date

January 12, 2024

Drug Information

Generic Name

精蛋白人胰岛素混合注射液(40R)

Trade Name

甘舒霖40R

Brand Name

甘舒霖40R

Dosage Form

注射剂

Strength

3ml:300单位(10.4mg)

Drug Type

生物制品

Registration Date

January 12, 2024

Company Information

Applicant Company

Company Name通化东宝药业股份有限公司

Company Address

通化县东宝新村

Manufacturing Company

Company Name通化东宝药业股份有限公司

Company Address

吉林省通化县东宝新村

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

精蛋白人胰岛素混合注射液(40R) - NMPA 批准文号 | MedPath